Curis Reports Dosing of First Patient in Phase 1 Trial of CUDC-907; FUJIFILM Completes Acquisition of Kalon Biotherapeutics

Print E-mail
By William Kent   
Thursday, 18 December 2014 20:14
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 18, 2014.
Read more...
 

Cara Announces Positive Top-Line Data from Phase 1b Trial of IV CR845; Provectus To Sponsor American Association Of Physicians Of Indian Origin

Print E-mail
By Marilyn Mullen   
Wednesday, 17 December 2014 19:46
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 17, 2014.
Read more...
 

TPI Expects To Receive GMP By End Of 2014; InVivo Reports FDA Approval to Expedite Enrollment for Pilot Trial

Print E-mail
By Marilyn Mullen   
Tuesday, 16 December 2014 19:49

Below is a look at some of the headlines for companies that made news in the healthcare sector on December 16, 2014.

Read more...
 

Prothena Receives FDA Fast Track Designation for NEOD001; FDA Confirms Lipocine's Plan for LPCN 1021

Print E-mail
By William Kent   
Monday, 15 December 2014 21:22
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 15, 2014.
Read more...
 

ChemoCentryx's Lead Drug Meets Phase II Objective; Novartis Reports Results of Trial Evaluating Use of Afinitor

Print E-mail
By William Kent   
Friday, 12 December 2014 18:58
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 12, 2014.
Read more...
 

Nektar Offers Data on Sub-Study of Phase 3 BEACON Study of NKTR-102; NewLink Genetics Sinks On Temporary Halt Of Ebola Trial

Print E-mail
By Josh Gee   
Thursday, 11 December 2014 19:03
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 11, 2014.
Read more...
 

Phase 3 PREVAIL Trial Named Clinical Advance of the Year by SCRIP; Teva Announces Launch of First Generic Celebrex® Capsules

Print E-mail
By Marilyn Mullen   
Wednesday, 10 December 2014 19:47

Below is a look at some of the headlines for companies that made news in the healthcare sector on December 10, 2014.

Read more...
 

Jazz Pharma and Concert Pharma Provide JZP-386 Update; ARIAD Reports Follow-up Data from Phase 1, PACE Trials of Ponatinib

Print E-mail
By William Kent   
Tuesday, 09 December 2014 20:13
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 9, 2014.
Read more...
 

CEL-SCI Expands Its Pivotal Phase III Immunotherapy Cancer Trial; Karyopharm to Present Clinical Data Update for Selinexor (KPT-330)

Print E-mail
By Josh Gee   
Monday, 08 December 2014 19:43
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 8, 2014.
Read more...
 

Apricus Announces First Patient Enrolled in Phase 2a Clinical Trial for RayVa(TM); Keryx Announces Issuance of a New U.S. Patent for Auryxia(TM)

Print E-mail
By Josh Gee   
Thursday, 04 December 2014 16:04
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 4, 2014.
Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 352

Newsletter

BioMedReports Aratana Therapeutics Inc (NASDAQ:PETX) Hits 5-Month High On Positive development: After the announcement of p... http://t.co/xsLwjGgVSe
21hreplyretweetfavorite
BioMedReports Doug Loe: Canada Has Earned Its Spot in the Biotech All-Star Team Photo: Biotech investors in the United State... http://t.co/TQiDczlMjS
BioMedReports Auspex Pharmaceuticals Inc (NASDAQ:ASPX) Gains Momentum After The Results From Phase Iii Study: Shares of Ausp... http://t.co/Uj6J7ynsH2
Benzinga.com supporter Seeking Alpha Certified